Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

GLYDO

LIDOCAINE HYDROCHLORIDE

Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview GLYDO is listed in Drugs@FDA under application 201094 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LIDOCAINE HYDROCHLORIDE Form and strength JELLY;TOPICAL - 2% Sponsor SAGENT PHARMS INC Submission history Latest submission status date: 2019-10-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview GLYDO is listed in Drugs@FDA under application 201094 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LIDOCAINE HYDROCHLORIDE Form and strength JELLY;TOPICAL - 2% Sponsor SAGENT PHARMS INC Submission history Latest submission status date: 2019-10-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.